Evaluating the SWW Method Dietary Intervention for HbA1c and Weight Management as a Preventative Intervention in Women

Completed · Not applicable

Conditions studied: Metabolic Syndrome, Obesity & Overweight, Blood Glucose Monitoring, Type 2 Diabetes Prevention

In brief

This study evaluated the SWW Method®, a 12-week dietary and lifestyle intervention based on the carbohydrate-insulin model, in a healthy cohort of women aged 35-75. The study assessed whether the intervention resulted in significant improvements in blood glucose markers (HbA1c, fasting blood glucose), weight, BMI, and other metabolic markers compared to a no-intervention control group. The SWW Method® protocol includes intermittent fasting, a protein-forward diet, meal sequencing, hydration, magnesium supplementation, and sleep support. This was a non-randomized case-control trial with 45 intervention participants and 40 controls, conducted over 12 weeks.

Key facts

Study ID

NCT07463417

Run by

Sarah Wragge Wellness

People needed

85

Starts

2024-04-01

Expected to finish

2025-08-31

Last updated by the study team

2026-03-12

Who can join

Age: 35 and older, up to 75. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• Female
• 35-75 years of age
• No prior enrollment in the SWW Method® or Sarah Wragge Wellness® program.

You may not qualify if…

• History of non-skin-related cancer diagnosis or treatment within the past five years.
• Currently taking weight loss medication, including semaglutide
• Currently taking any medication for blood sugar or diabetes management.
• Previous enrollment in the SWW Method® or any Sarah Wragge Wellness® program.

Where it is running

• Sarah Wragge Wellness — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.